Last updated: September 8, 2021
Sponsor: Karolinska University Hospital
Overall Status: Completed
Phase
N/A
Condition
Liver Disease
Primary Biliary Cholangitis
Gall Bladder Disorders
Treatment
N/AClinical Study ID
NCT01556555
552/03
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- sclerosing cholangitis with indication for ERCP
- Over 18 year
- informed consent
Exclusion
Exclusion Criteria:
- Not able to sign informed consent
Study Design
Total Participants: 46
Study Start date:
September 01, 2008
Estimated Completion Date:
October 31, 2011
Connect with a study center
Karolinska University Hospital, Huddinge
Stockholm, 14186
SwedenSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.